Prof Amanda Page is a leading authority on vagal innervation of the gastrointestinal tract and how this relates to major disease states, including obesity. Her research has involved pioneering studies on the phenotypic specialisation of vagal sensory endings, and how these sensory subtypes can be modulated pharmacologically. This includes, establishment of the role of the circadian system in vagal afferent signalling and the disruption of this system in diet-induced obesity and shift work.
She graduated with a BSc(Hon) in Pharmacology at Liverpool University before embarking on a PhD within the Department of Anatomy and Developmental Biology at University College London. In 1995, on completion of her PhD, she moved to Adelaide, South Australia to take up a research position at the Royal Adelaide Hospital before moving across to The University of Adelaide. Her research group, the Gastrointestinal Vagal Afferent Research Group, forms part of the South Australian Health and Medical Research Institute Nutrition, Diabetes and Gut Health Program, for which she is Director. She is a basic scientist but her research has a strong clinical focus. Using a combination of behavioural, electrophysiological, molecular, anatomical and immunohistochemical techniques her group aims to understand the role of vagal afferents in mediating the development of obesity and/or resistance to weight loss and to identify modifiable targets for the pharmacotherapy of obesity.
Prof Amanda Page is a leading authority on vagal innervation of the gastrointestinal tract and how this relates to major disease states, including obesity. Her research has involved pioneering studies on the phenotypic specialisation of vagal sensory endings, and how these sensory subtypes can be modulated pharmacologically. This includes, establishment of the role of the circadian system in vagal afferent signalling and the disruption of this system in diet-induced obesity and shift work.
She graduated with a BSc(Hon) in Pharmacology at Liverpool University before embarking on a PhD within the Department of Anatomy and Developmental Biology at University College London. In 1995, on completion of her PhD, she moved to Adelaide, South Australia to take up a research position at the Royal Adelaide Hospital before moving across to The University of Adelaide. Her research group, the Gastrointestinal Vagal Afferent Research Group, forms part of the South Australian Health and Medical Research Institute Nutrition, Diabetes and Gut Health Program, for which she is Director. She is a basic scientist but her research has a strong clinical focus. Using a combination of behavioural, electrophysiological, molecular, anatomical and immunohistochemical techniques her group aims to understand the role of vagal afferents in mediating the development of obesity and/or resistance to weight loss and to identify modifiable targets for the pharmacotherapy of obesity.